Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca

Cornea

Volumn 24, Issue 1, 2005, Pages 80-85

  Strong, Bradley ^a   Farley, William ^a   Stern, Michael E ^b   Pflugfelder, Stephen C ^a  

^a CULLEN EYE INSTITUTE   (United States)

^b ALLERGAN INC   (United States)

Author keywords

Apoptosis; Cyclosporine; Dry eye; Keratoconjunctivitis sicca

Indexed keywords

CASPASE 3; CYCLOSPORIN A; DNA FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL LOSS; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVATION; FROZEN SECTION; GOBLET CELL; HUMIDITY; IMMUNOHISTOCHEMISTRY; KERATOCONJUNCTIVITIS SICCA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, TOPICAL; ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; CELL COUNT; CONJUNCTIVA; CYCLOSPORINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GOBLET CELLS; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; KERATOCONJUNCTIVITIS SICCA; MICE; MICE, INBRED C57BL; OPHTHALMIC SOLUTIONS; SCOPOLAMINE;

EID: 11144230017     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000133994.22392.47     Document Type: Article

References (15)

1. Gao J, Schwalb TA, Addeo JV, et al. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of cyclosporin A therapy. Cornea. 1998;17:654-663.
2. Yeh S, Song XJ, Farley W, et al. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci. 2003;44:124-129.
3. Sall K, Stevenson OD, Mundorf TK, et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107:631-639.
4. Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome dry eye with cyclosporine. Arch Ophthalmol. 2002;120:330-337.
5. Brignole F, Pisella PJ, De Saint Jean M, et al. Flow cytometric analysis of inflammatory makers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci. 2001;42:90-95.
6. Pflugfelder SC, Tseng SCG, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea. 1998;17:38-56.
7. Chodosh J, Dix RD, Howell RC, et al. Staining characteristics and antiviral viral activity of sulforhodamine B and lissamine green B. Invest Ophthalmol Vis Sci. 1994;35:1046-1058.
8. Pflugfelder SC, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjuncitivitis sicca. Curr Eye Res. 1999;19:201-222.
9. Solomon A, Dursun D, Liu Z, et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Opthalmol Vis Sci. 2001;42:2283-2292.
10. Kunert KS, Tisdale AS, Stern ME, et al. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol. 2000;118:1489-1496.
11. Jacotot E, Costantini P, Laboureau E, et al. Mitochondrial membrane permeabilization during the apoptotic process. Ann NY Acad Sci. 1999;887:18-30.
12. Nunez G, Benedict MA, Hu Y, et al. Caspases: the proteases of the apoptotic pathway. Oncogene. 1998;17:3237-3245.
13. Halestrap AP, McStay GP, Clarke SJ. The permeability transition pore complex: another view. Biochimie. 2002;84:153-166.
14. Friberg H, Ferrand-Drake M, Bengtsson F, et al. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci. 1998;18:5151-5159.
15. Ferrand-Drake M, Zhu C, Gido G, et al. Cyclosporin A prevents calpain activation despite increased intracellular calcium concentrations, as well as translocation of apoptosis-inducing factor, cytochrome c and caspase-3 activation in neurons exposed to transient hypoglycemia. J Neurochem. 2003;85:1431-1442.